Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- TOPICS 2 articles
July 26, 2004
- NEW PRODUCT
July 26, 2004
- Semi-annual Business Results
July 26, 2004
- GSK Developing Multiple Kinase Inhibitors: GSK Symposium 2004
July 26, 2004
- WORLD NEWS IN BRIEF
July 26, 2004
- PRESS SEMINAR
July 26, 2004
- 2 WG to Discuss Problems with Drug Distribution: Ryukaikon
July 26, 2004
- RESEARCH & DEVELOPMENT NEWS IN BRIEF
July 26, 2004
- Import of Zometa Inj 4 mg Approved
July 26, 2004
- MEDICAL DEVICE NEWS IN BRIEF
July 26, 2004
- Supplementary Notification on Amended PAL Issued
July 26, 2004
- DIAGNOSTIC NEWS IN BRIEF
July 26, 2004
- Mr Asonuma Reviews 1st Year of New PAL Enforcement
July 26, 2004
- Licensing Out POTTELIGENT Technology: Mr Matsuda of Kyowa Hakko
July 26, 2004
- REGULATORY NEWS IN BRIEF
July 26, 2004
- Interpretation on Reimbursement of Off-label Use Issued by HIB
July 26, 2004
- Over 50% of Directors of Private Hospitals Support Management by Stock Companies
July 26, 2004
- FY2004 Is Critical for Restoring Good Financial Results: Mr Miyatake of Dainippon
July 19, 2004
- Takara Bio Supplies RetroNectin to NCI of the US for Gene Therapy Trial
July 19, 2004
- MEDICAL DEVICE NEWS IN BRIEF
July 19, 2004
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…